TSC2: filling the GAP in the mTOR signaling pathway

Related Experiment Video

Updated: Aug 29, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Yong Li1, Michael N Corradetti, Ken Inoki

  • 1Department of Biological Chemistry and Life Sciences Institute, University of Michigan, Ann Arbor, MI 48109, USA.

Trends in Biochemical Sciences
|January 20, 2004
PubMed

Insights

The tumor suppressor proteins TSC1/2 inhibit cell growth by controlling the mTOR pathway. This research reveals TSC1/2 and Rheb’s role in nutrient and growth factor signaling to mTOR, offering new insights into tuberous sclerosis complex pathogenesis.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Genetics

Background:

  • Tuberous sclerosis complex (TSC) is an autosomal dominant disorder linked to tumor suppressor proteins TSC1 and TSC2.
  • TSC1 and TSC2 form a heterodimer that inhibits cell growth and proliferation.
  • Mammalian target of rapamycin (mTOR) is a key regulator of cell growth, responding to nutrients, energy, and growth factors.

Purpose of the Study:

  • To elucidate the molecular mechanisms linking TSC1/2 to the mTOR signaling network.
  • To understand the role of TSC1/2 and Rheb in mediating cellular signals to mTOR-dependent pathways.

Main Methods:

  • Investigated the GTPase-activating protein (GAP) activity of TSC2 towards Rheb.
  • Analyzed the interaction between TSC1/2, Rheb, and the mTOR signaling pathway.

Main Results:

  • TSC2 exhibits GTPase-activating protein (GAP) activity toward the small GTPase Rheb.
  • The TSC1/2 heterodimer antagonizes the mTOR signaling pathway by stimulating GTP hydrolysis of Rheb.
  • TSC1/2 and Rheb are identified as crucial mediators of growth factor, nutrient, and energy signals to mTOR.

Conclusions:

  • The TSC1/2-Rheb interaction is a critical node in cellular signaling, connecting environmental cues to mTOR-dependent growth control.
  • These findings provide novel insights into the pathogenesis of tuberous sclerosis complex (TSC).

More Related Videos

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method08:04

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method

Published on: October 23, 2018

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...